NCT02591771View on ClinicalTrials.gov

Study of Multistep Pharmacological and Invasive Management for Cardiogenic Shock

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

July 25, 2017

Study Completion Date

December 31, 2017

Conditions
Cardiogenic Shock
Interventions
DRUG

adrenaline

i.v. adrenaline infusion as an early and fast haemodynamic stabilizer, associated with a tight tissue perfusion monitoring, in the context of a stepwise progression in the treatment of cardiogenic shock, including ventricular mechanical support

Trial Locations (2)

20132

Ospedale San Raffaele, Milan

20162

Niguarda Hospital, Milan

All Listed Sponsors
collaborator

Ospedale San Raffaele

OTHER

lead

Niguarda Hospital

OTHER

NCT02591771 - Study of Multistep Pharmacological and Invasive Management for Cardiogenic Shock | Biotech Hunter | Biotech Hunter